ImmunoPrecise Antibodies Ltd (NASDAQ:IPA)’s traded shares stood at 0.94 million during the latest session, with the company’s beta value hitting 0.30. At the last check today, the stock’s price was $0.40, to imply a decrease of -0.04% or $0.0 in intraday trading. The IPA share’s 52-week high remains $1.40, putting it -250.0% down since that peak but still an impressive 32.5% since price per share fell to its 52-week low of $0.27. The company has a valuation of $18.34M, with an average of 0.42 million shares in intraday trading volume over the past 10 days and average of 7.56 million shares over the past 3 months.
ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) trade information
After registering a -0.04% downside in the latest session, ImmunoPrecise Antibodies Ltd (IPA) has traded red over the past five days. The 5-day price performance for the stock is 11.38%, and -1.02% over 30 days. With these gigs, the year-to-date price performance is -2.64%. Short interest in ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) saw shorts transact 3.03 million shares and set a 0.64 days time to cover.
ImmunoPrecise Antibodies Ltd (IPA) estimates and forecasts
The rating firms project that company’s revenue will grow 3.72% compared to the previous financial year.
Revenue forecast for the current quarter as set by 2 analysts is 7.89M.
IPA Dividends
ImmunoPrecise Antibodies Ltd has its next earnings report out on 2025-Mar-27. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
ImmunoPrecise Antibodies Ltd (NASDAQ:IPA)’s Major holders
ImmunoPrecise Antibodies Ltd insiders hold 5.21% of total outstanding shares, with institutional holders owning 4.17% of the shares at 4.40% float percentage. In total, 4.17% institutions holds shares in the company, led by INGALLS & SNYDER LLC. As of 2024-06-30, the company held over 1.3 million shares (or 5.0209% of shares), all amounting to roughly $1.31 million.
The next major institution holding the largest number of shares is RENAISSANCE TECHNOLOGIES LLC with 63910.0 shares, or about 0.2477% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $64549.0.
Going by data provided on Feb 28, 2025 , Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund holds roughly 10.67 shares. This is just over 0.04% of the total shares, with a market valuation of $4190.0
